Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v2-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2020-10-28 | 2020-10-28 |
| Drug Identification Number | 02400995 | 02400995 |
| Brand name | PICATO | PICATO |
| Common or Proper name | ingenol mebutate | ingenol mebutate |
| Company Name | LEO PHARMA INC | LEO PHARMA INC |
| Ingredients | INGENOL MEBUTATE | INGENOL MEBUTATE |
| Strength(s) | 0.05% | 0.05% |
| Dosage form(s) | GEL | GEL |
| Route of administration | TOPICAL TOPICAL | TOPICAL TOPICAL |
| Packaging size | 2 x 0.47g | 2 x 0.47g |
| ATC code | D06BX | D06BX |
| ATC description | CHEMOTHERAPEUTICS FOR TOPICAL USE | CHEMOTHERAPEUTICS FOR TOPICAL USE |
| Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2020-10-14 | 2020-10-14 |
| Remaining supply date | 2020-12-11 | 2020-12-11 |
| Discontinuation status | Discontinued | Discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | On October 14, 2020, Health Canada directed LEO Pharma Inc. to stop the sale of PICATO at the manufacturer level. | On October 14, 2020, Health Canada directed LEO Pharma Inc. to stop the sale of PICATO at the manufacturer level. |
| Health Canada comments |